Friday Satellite Symposia

The Friday Satellite Symposia (FSS) are industry-supported, CME-certified symposia that are offered the day preceding the American Society of Hematology (ASH) annual meeting. These sessions are not part of the official ASH annual meeting program and are planned solely by the sponsoring company.

The 2020 FSS will be a virtual experience taking place on Friday, December 4, 2020. The application period closed on June 15, 2020 at 11:59 p.m. PST. The FSS program will be available in August 2020.

Please review the official FSS guidelines to learn about hosting a symposium.

ASH appreciates its corporate and nonprofit partners for their participation in FSS. The Society values its partnerships and the supportive role that members of this community play in an effort to provide hematologists with quality educational programs.

For more information, contact Kelly Cade, ASH FSS Manager, Consultant, at fss@hematology.org.

Friday Satellite Symposia

A Case-based Workshop: Clinical and Laboratory Aspects of Hemophilia and Thrombosis

Chairs:

Speakers:

Registration:

Acute Myeloid Leukemia: Using Available Evidence and Guidelines to Make Sense of a Rapidly Evolving Treatment Paradigm

Chair:

Speakers:

Registration:

Advances in Diagnosis and Management of Myelodysplastic Syndromes

Chair:

Speakers:

Registration:

An Optimized Approach to Sickle Cell Disease Care in a New Era of Treatment

Chair:

Speakers:

Registration:

Application of Individualized Treatment for CLL/SLL: Novel Agents, Combinations, and Sequencing Therapy

Chair:

Speakers:

Registration:

Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Patients with Multiple Myeloma (Part 1 of a 4-Part Series)

Chair:

Speakers:

Registration:

Exploring Antibody Therapy in ALL: How and Why to Integrate Antibody-Based Treatment Into Patient Management

Chair:

Speakers:

Registration:

How I Think, How I Treat in the New Age of AML Care: Personal Perspectives on New Evidence and Innovative Therapeutics

Chairs:

Speakers:

Registration:

Managing Myeloma: Where We Are, Where We’re Going, and Where We SHOULD Be Going (Time to Choose Sides!)

Chairs:

Speakers:

Registration:

Mapping the New Era in CLL Management: Precision Medicine, Optimized Therapeutic Sequencing, and Patient Perspectives in Treatment-Naïve and Relapsed Disease

Chair:

Speakers:

Registration:

Mastering the Treatment of Myeloid Malignancies in the Era of Personalized Medicine

Chair:

Speakers:

Registration:

Preparing for Personalized Care in MDS: Integrating Innovative Treatments Into a Cohesive Patient Care Model

Chair:

Speakers:

Registration:

Understanding Cold Agglutinin Disease: How Do Emerging Treatment Options Have the Potential to Transform Patient Outcomes?

Chair:

Speakers:

Registration:

Accelerating Toward a Cure for Myeloma: Emerging Data, New Agents, and an Evolving Treatment Paradigm

Chair:

Speakers:

Registration:

Advances in GvHD: Expert Guidance on the Current Treatment Landscape, Optimizing Prophylaxis, and Integrating Novel Therapies

Chair:

Speakers:

Registration:

Advances in Therapy for Inherited Non-Malignant Blood Disorders: Focus on Sickle Cell Disease and Hemophilia.

Chair:

Speakers:

Registration:

Building New Management Models for NHL Care: A Seminar and Tumor Board on Innovative Chemo-sparing, Targeted, and Cellular Therapies in FL and DLBCL

Chair:

Speakers:

Registration:

Clinical Advances in Immune Thrombocytopenia: Integrating New Therapies

Chair:

Speakers:

Registration:

Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Patients with Chronic Lymphocytic Leukemia (Part 2 of a 4-Part Series)

Chair:

Speakers:

Registration:

D is for Diagnosis: Detecting and Treating Rare Disorders in Hematologic Practice

Chair:

Speakers: